| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Medicine, Veterans Affairs Medical Center and University of Iowa, Iowa City, IA 52242
Phosphorothioate oligodeoxynucleotides containing CpG (CpG-ODN) activate immune responses. We report that quinacrine, chloroquine, and structurally related compounds completely inhibit the antiapoptotic effect of CpG-ODN on WEHI 231 murine B lymphoma cells and inhibit CpG-ODN-induced secretion of IL-6 by WEHI 231. They also inhibit IL-6 synthesis and thymidine uptake by human unfractionated PBMC induced by CpG-ODN. The compounds did not inhibit LPS-induced responses. Half-maximal inhibition required 10 nM quinacrine or 100 nM chloroquine. Inhibition was noncompetitive with respect to CpG-ODN. Quinine, quinidine, and primaquine were much less powerful. Quinacrine was effective even when added after the CpG-ODN. Near-toxic concentrations of ammonia plus bafilomycin A1 (used to inhibit vesicular acidification) did not reduce the efficacy of the quinacrine, but the effects of both quinacrine and chloroquine were enhanced by inhibition of the multidrug resistance efflux pump by verapamil. Agents that bind to DNA, including propidium iodide, Hoechst dye 33258, and coralyne chloride did not inhibit CpG-ODN effect, nor did 4-bromophenacyl bromide, an inhibitor of phospholipase A2. Examination of the structure-activity relationship of seventy 4-aminoquinoline and 9-aminoacridine analogues reveals that increased activity was conferred by bulky hydrophobic substituents on positions 2 and 6 of the quinoline nucleus. No correlation was found between published antimalarial activity and ability to block CpG-ODN-induced effects. These results are discussed in the light of the ability of quinacrine and chloroquine to induce remission of rheumatoid arthritis and lupus erythematosus.
This article has been cited by other articles:
|
|
 |
|
  G. Chikh, S. D. de Jong, L. Sekirov, S. G. Raney, M. Kazem, K. D. Wilson, P. R. Cullis, J. P. Dutz, and Y. K. Tam Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles Int. Immunol., July 1, 2009; 21(7): 757 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N.-H. Chang, T. McKenzie, G. Bonventi, C. Landolt-Marticorena, P. R. Fortin, D. Gladman, M. Urowitz, and J. E. Wither Expanded Population of Activated Antigen-Engaged Cells within the Naive B Cell Compartment of Patients with Systemic Lupus Erythematosus J. Immunol., January 15, 2008; 180(2): 1276 - 1284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ivanov, A.-M. Dragoi, X. Wang, C. Dallacosta, J. Louten, G. Musco, G. Sitia, G. S. Yap, Y. Wan, C. A. Biron, et al. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA Blood, September 15, 2007; 110(6): 1970 - 1981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Berghofer, G. Haley, T. Frommer, G. Bein, and H. Hackstein Natural and Synthetic TLR7 Ligands Inhibit CpG-A- and CpG-C-Oligodeoxynucleotide-Induced IFN-{alpha} Production J. Immunol., April 1, 2007; 178(7): 4072 - 4079. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Andersen, D. Al-Khairy, and R. R. Ingalls Innate Immunity at the Mucosal Surface: Role of Toll-Like Receptor 3 and Toll-Like Receptor 9 in Cervical Epithelial Cell Responses to Microbial Pathogens Biol Reprod, May 1, 2006; 74(5): 824 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Adamsson, M. Lindblad, A. Lundqvist, D. Kelly, J. Holmgren, and A. M. Harandi Novel immunostimulatory agent based on CpG oligodeoxynucleotide linked to the nontoxic B subunit of cholera toxin. J. Immunol., April 15, 2006; 176(8): 4902 - 4913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Sanjuan, N. Rao, K.-T. A. Lai, Y. Gu, S. Sun, A. Fuchs, W.-P. Fung-Leung, M. Colonna, and L. Karlsson CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion. J. Cell Biol., March 27, 2006; 172(7): 1057 - 1068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Roberts, J. A. Dunn, T. D. Terry, M. P. Jennings, D. A. Hume, M. J. Sweet, and K. J. Stacey Differences in Macrophage Activation by Bacterial DNA and CpG-Containing Oligonucleotides J. Immunol., September 15, 2005; 175(6): 3569 - 3576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Roberts, M. J. Sweet, D. A. Hume, and K. J. Stacey Cutting Edge: Species-Specific TLR9-Mediated Recognition of CpG and Non-CpG Phosphorothioate-Modified Oligonucleotides J. Immunol., January 15, 2005; 174(2): 605 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Coban, K. J. Ishii, T. Kawai, H. Hemmi, S. Sato, S. Uematsu, M. Yamamoto, O. Takeuchi, S. Itagaki, N. Kumar, et al. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin J. Exp. Med., January 3, 2005; 201(1): 19 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Marshak-Rothstein, L. Busconi, C. M. Lau, A. S. Tabor, E. A. Leadbetter, S. Akira, A. M. Krieg, G. B. Lipford, G. A. Viglianti, and I. R. Rifkin Comparison of CpG s-ODNs, chromatin immune complexes, and dsDNA fragment immune complexes in the TLR9-dependent activation of rheumatoid factor B cells Innate Immunity, August 1, 2004; 10(4): 247 - 251. [Abstract] [PDF]
|
|
|
|
|
|
M. W. Boule, C. Broughton, F. Mackay, S. Akira, A. Marshak-Rothstein, and I. R. Rifkin Toll-like Receptor 9-Dependent and -Independent Dendritic Cell Activation by Chromatin-Immunoglobulin G Complexes J. Exp. Med., June 21, 2004; 199(12): 1631 - 1640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cornelie, J. Hoebeke, A.-M. Schacht, B. Bertin, J. Vicogne, M. Capron, and G. Riveau Direct Evidence that Toll-like Receptor 9 (TLR9) Functionally Binds Plasmid DNA by Specific Cytosine-phosphate-guanine Motif Recognition J. Biol. Chem., April 9, 2004; 279(15): 15124 - 15129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Storni, C. Ruedl, K. Schwarz, R. A. Schwendener, W. A. Renner, and M. F. Bachmann Nonmethylated CG Motifs Packaged into Virus-Like Particles Induce Protective Cytotoxic T Cell Responses in the Absence of Systemic Side Effects J. Immunol., February 1, 2004; 172(3): 1777 - 1785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Kumaraguru, C. D. Pack, and B. T. Rouse Toll-like receptor ligand links innate and adaptive immune responses by the production of heat-shock proteins J. Leukoc. Biol., May 1, 2003; 73(5): 574 - 583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Datta, V. Redecke, K. R. Prilliman, K. Takabayashi, M. Corr, T. Tallant, J. DiDonato, R. Dziarski, S. Akira, S. P. Schoenberger, et al. A Subset of Toll-Like Receptor Ligands Induces Cross-presentation by Bone Marrow-Derived Dendritic Cells J. Immunol., April 15, 2003; 170(8): 4102 - 4110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-G. Zhu, C. F. Reich, and D. S. Pisetsky Inhibition of murine dendritic cell activation by synthetic phosphorothioate oligodeoxynucleotides J. Leukoc. Biol., December 1, 2002; 72(6): 1154 - 1163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Gao, S. Parkin, P. F. Johnson, and R. C. Schwartz C/EBPgamma Has a Stimulatory Role on the IL-6 and IL-8 Promoters J. Biol. Chem., October 4, 2002; 277(41): 38827 - 38837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Reddy, K.-H. K. Hsiao, V. E. Abernethy, H. Fan, A. Longacre, W. Lieberthal, J. Rauch, J. S. Koh, and J. S. Levine Phagocytosis of Apoptotic Cells by Macrophages Induces Novel Signaling Events Leading to Cytokine-Independent Survival and Inhibition of Proliferation: Activation of Akt and Inhibition of Extracellular Signal-Regulated Kinases 1 and 2 J. Immunol., July 15, 2002; 169(2): 702 - 713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-H. Chuang, J. Lee, L. Kline, J. C. Mathison, and R. J. Ulevitch Toll-like receptor 9 mediates CpG-DNA signaling J. Leukoc. Biol., March 1, 2002; 71(3): 538 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. ZOU, H. SCHWARTZ, S. ENDRES, G. HARTMANN, and Z. BAR-SHAVIT CpG oligonucleotides: novel regulators of osteoclast differentiation FASEB J, March 1, 2002; 16(3): 274 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hayashi, S. P. Rao, K. Takabayashi, J. H. Van Uden, R. S. Kornbluth, S. M. Baird, M. W. Taylor, D. A. Carson, A. Catanzaro, and E. Raz Enhancement of Innate Immunity against Mycobacterium avium Infection by Immunostimulatory DNA Is Mediated by Indoleamine 2,3-Dioxygenase Infect. Immun., October 1, 2001; 69(10): 6156 - 6164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Dalpke, S. Opper, S. Zimmermann, and K. Heeg Suppressors of Cytokine Signaling (SOCS)-1 and SOCS-3 Are Induced by CpG-DNA and Modulate Cytokine Responses in APCs J. Immunol., June 15, 2001; 166(12): 7082 - 7089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Liang, C. F. Reich, D. S. Pisetsky, and P. E. Lipsky The Role of Cell Surface Receptors in the Activation of Human B Cells by Phosphorothioate Oligonucleotides J. Immunol., August 1, 2000; 165(3): 1438 - 1445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Hartmann and A. M. Krieg Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells J. Immunol., January 15, 2000; 164(2): 944 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Sester, S. J. Beasley, M. J. Sweet, L. F. Fowles, S. L. Cronau, K. J. Stacey, and D. A. Hume Bacterial/CpG DNA Down-Modulates Colony Stimulating Factor-1 Receptor Surface Expression on Murine Bone Marrow-Derived Macrophages with Concomitant Growth Arrest and Factor-Independent Survival J. Immunol., December 15, 1999; 163(12): 6541 - 6550. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Manzel, L. Strekowski, F. M. D. Ismail, J. C. Smith, and D. E. Macfarlane Antagonism of Immunostimulatory CpG-Oligodeoxynucleotides by 4-Aminoquinolines and Other Weak Bases: Mechanistic Studies J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1337 - 1347. [Abstract] [Full Text]
|
|
|
|
|
|
A.-K. Yi, D. W. Peckham, R. F. Ashman, and A. M. Krieg CpG DNA rescues B cells from apoptosis by activating NF{kappa}B and preventing mitochondrial membrane potential disruption via a chloroquine-sensitive pathway Int. Immunol., December 1, 1999; 11(12): 2015 - 2024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Gao, E. G. Zuvanich, Q. Xue, D. L. Horn, R. Silverstein, and D. C. Morrison Cutting Edge: Bacterial DNA and LPS Act in Synergy in Inducing Nitric Oxide Production in RAW 264.7 Macrophages J. Immunol., October 15, 1999; 163(8): 4095 - 4099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-K. Yi and A. M. Krieg Cutting Edge: Rapid Induction of Mitogen-Activated Protein Kinases by Immune Stimulatory CpG DNA J. Immunol., November 1, 1998; 161(9): 4493 - 4497. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
